A comparative study of Lrrk2 function in primary neuronal cultures.
暂无分享,去创建一个
M. Yue | M. Farrer | Justus C Dächsel | B. Behrouz | J. E. Beevers | H. Melrose | Mei Yue | Bahareh Behrouz | Matthew J Farrer | Joel E Beevers | Heather L Melrose | J. Dächsel | Joel E. Beevers | Mei Yue
[1] M. Cookson,et al. Leucine-rich repeat kinase 2 mutations and Parkinson’s disease: three questions , 2009, ASN neuro.
[2] L. Cantley,et al. Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson's disease. , 2009, The Biochemical journal.
[3] T. Dawson,et al. Dynamic and redundant regulation of LRRK2 and LRRK1 expression , 2007, BMC Neuroscience.
[4] S. Blanchard,et al. Alsin/Rac1 signaling controls survival and growth of spinal motoneurons , 2006, Annals of neurology.
[5] C. Ross,et al. Kinase activity of mutant LRRK2 mediates neuronal toxicity , 2006, Nature Neuroscience.
[6] M. Cookson,et al. The Parkinson Disease-associated Leucine-rich Repeat Kinase 2 (LRRK2) Is a Dimer That Undergoes Intramolecular Autophosphorylation* , 2008, Journal of Biological Chemistry.
[7] I. Marín,et al. The Roco protein family: a functional perspective , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[8] R. Burke,et al. Mutant LRRK2R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease , 2009, Nature Neuroscience.
[9] M. H. Park,et al. Staurosporin induces neurite outgrowth through ROS generation in HN33 hippocampal cell lines , 2006, Journal of Neural Transmission.
[10] J. Jankovic,et al. Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families , 2007, Movement disorders : official journal of the Movement Disorder Society.
[11] B. Giasson,et al. Identification of compounds that inhibit the kinase activity of leucine-rich repeat kinase 2. , 2009, Biochemical and biophysical research communications.
[12] W. Dauer,et al. The Parkinson Disease Protein Leucine-Rich Repeat Kinase 2 Transduces Death Signals via Fas-Associated Protein with Death Domain and Caspase-8 in a Cellular Model of Neurodegeneration , 2009, The Journal of Neuroscience.
[13] David I. Bass,et al. A comparative analysis of leucine-rich repeat kinase 2 (Lrrk2) expression in mouse brain and Lewy body disease , 2007, Neuroscience.
[14] M. Cookson,et al. Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase , 2008, Proceedings of the National Academy of Sciences.
[15] M. Farrer,et al. Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia. , 2007, Parkinsonism & related disorders.
[16] H. Yoshikawa,et al. IL-1beta promotes neurite outgrowth by deactivating RhoA via p38 MAPK pathway. , 2008, Biochemical and Biophysical Research Communications - BBRC.
[17] A. Abeliovich,et al. The Familial Parkinsonism Gene LRRK2 Regulates Neurite Process Morphology , 2006, Neuron.
[18] H. Yoshikawa,et al. IL-1β promotes neurite outgrowth by deactivating RhoA via p38 MAPK pathway , 2008 .
[19] Y. Ohizumi,et al. Nardosinone, the first enhancer of neurite outgrowth-promoting activity of staurosporine and dibutyryl cyclic AMP in PC12D cells. , 2003, Brain research. Developmental brain research.
[20] H. Cai,et al. Phosphorylation of Ezrin/Radixin/Moesin Proteins by LRRK2 Promotes the Rearrangement of Actin Cytoskeleton in Neuronal Morphogenesis , 2009, The Journal of Neuroscience.
[21] P. V. van Haastert,et al. Roc, a Ras/GTPase domain in complex proteins. , 2003, Biochimica et biophysica acta.
[22] E. Tolosa,et al. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study , 2008, The Lancet Neurology.
[23] J. Vickers,et al. Rho kinase activates ezrin‐radixin‐moesin (ERM) proteins and mediates their function in cortical neuron growth, morphology and motility in vitro , 2007, Journal of neuroscience research.
[24] P. Matthews,et al. LRRK2 Gly2019Ser penetrance in Arab–Berber patients from Tunisia: a case-control genetic study , 2008, The Lancet Neurology.
[25] 井口 洋平. TDP-43 depletion induces neuronal cell damage through dysregulation of Rho family GTPases , 2010 .
[26] P. Bickford,et al. Developmental regulation of leucine-rich repeat kinase 1 and 2 expression in the brain and other rodent and human organs: Implications for Parkinson’s disease , 2008, Neuroscience.
[27] C. Chu,et al. Role of autophagy in G2019S‐LRRK2‐associated neurite shortening in differentiated SH‐SY5Y cells , 2008, Journal of neurochemistry.
[28] M. Cookson,et al. The Parkinson's disease kinase LRRK2 autophosphorylates its GTPase domain at multiple sites. , 2009, Biochemical and biophysical research communications.